United States

Q1 2021 Dealmaker Roundup

Life sciences gets a COVID booster shot


In this edition of the Dealmaker Roundup, RSM’s Life Sciences Senior Analyst, Adam Lohr, and Jamie Hendershot, Transaction Advisory Director, along with Sean Cunningham, Managing Director at GTCR, share insights about dramatic changes in the industry over the pandemic year.

This Privcap hosted discussion addresses:

  • What's driving the surging IPO market for biotech companies,
  • How clinical trials have continued apace during COVID,
  • Considerations for investing in tool-making companies versus drug developers, and 
  • The need for private equity partners to bring more to the table than just money. 

Related content

How can we help you?

Events / Webcasts


Credit Fund Webcast Series: Market data and economic update

  • October 27, 2020


Enhancing family offices – webcast series

  • September 30, 2020


Carried interest regulations: Update for investment fund managers

  • August 13, 2020